Financhill
Buy
90

BEAM Quote, Financials, Valuation and Earnings

Last price:
$34.01
Seasonality move :
-23.84%
Day range:
$29.16 - $36.44
52-week range:
$13.53 - $36.44
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
56.76x
P/B ratio:
3.54x
Volume:
7.1M
Avg. volume:
1.7M
1-year change:
27.66%
Market cap:
$3.4B
Revenue:
$63.5M
EPS (TTM):
-$4.43

Earnings Data

Next earnings date for BEAM
Feb 24
2026
Most recent earnings per share
-$1.10
Missed by $0.09
(Nov 4/2025)
Consensus Estimate
-$1.01
(Nov 4/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

BEAM Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/31/2026 Q1 $13.7M -- -- -$1.16 --
02/24/2026 Q4 $13.2M -- -- -$1.12 --
11/04/2025 Q3 $12.7M $9.7M -$1.10 -$1.01 -$0.09
08/05/2025 Q2 $13.3M $8.5M -$1.00 -$1.09 $0.09
05/06/2025 Q1 $14.7M $7.5M -$1.24 -$1.17 -$0.07
02/25/2025 Q4 $16.5M $30.1M -$1.09 -$1.22 $0.12
11/05/2024 Q3 $14.1M $14.3M -$1.17 -$1.18 $0.01
08/06/2024 Q2 $13M $11.8M -$1.11 -$1.12 $0.01
05/07/2024 Q1 $14.7M $7.4M -$1.21 -$1.39 $0.18
02/27/2024 Q4 $33.7M $316.2M $1.73 -$0.71 $2.44
11/08/2023 Q3 -- $17.2M -$1.22 -- --
08/08/2023 Q2 -- $20.1M -$1.08 -- --
05/10/2023 Q1 -- $24.2M -$1.33 -- --
02/28/2023 Q4 -- $20M -$0.54 -- --
11/07/2022 Q3 -- $15.8M -$1.56 -- --
08/09/2022 Q2 -- $16.7M -$1.02 -- --
05/09/2022 Q1 -- $8.4M -$1.01 -- --
02/28/2022 Q4 -- $51.1M -$0.95 -- --
11/08/2021 Q3 -- $763K -$0.42 -- --
08/10/2021 Q2 -- $6K -$1.23 -- --
05/11/2021 Q1 -- $6K -$3.35 -- --
03/30/2021 Q4 -- $6K -$1.69 -- --
11/10/2020 Q3 -- $6K -$0.69 -- --
08/12/2020 Q2 -- $6K -$0.69 -- --
05/12/2020 Q1 -- $6K -$1.03 -- --
03/30/2020 Q4 -- $6K -$0.61 -- --
09/30/2019 Q3 -- $6K -$0.43 -- --
06/30/2019 Q2 -- $6K -$0.41 -- --
03/31/2019 Q1 -- -- -$0.32 -- --
12/31/2018 Q4 -- -- -$0.51 -- --
09/30/2018 Q3 -- -- -$1.37 -- --

Beam Therapeutics, Inc. Earnings Questions

  • How Much did Beam Therapeutics, Inc. Generate in Revenue Last Quarter?

    Beam Therapeutics, Inc. reported $9.7M worth of top line sales in its most recent quarter.

  • Did Beam Therapeutics, Inc. Beat Earnings Last Quarter?

    Beam Therapeutics, Inc. announced earnings per share of -$1.10 which represents a miss of analyst forecast a -$1.01 per share.

  • Is Beam Therapeutics, Inc. Profitable?

    Beam Therapeutics, Inc. reported $4.1M that represents $0.04 per share over the last quarter.

  • What is the Analyst Consensus for Beam Therapeutics, Inc. EPS Next Year?

    Beam Therapeutics, Inc.'s earnings are forecast to decrease from -$4.58 per share to -$4.39 per share next year representing a decrease of -0.14%.

  • When is Beam Therapeutics, Inc.'s Earnings Date?

    Beam Therapeutics, Inc.'s next earnings date is February 24, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Is Amkor Stock Up So Much?
Why Is Amkor Stock Up So Much?

Semiconductor packaging and testing major Amkor (NASDAQ:AMKR) has started 2026…

Is Shopify Stock a Good Buy Now?
Is Shopify Stock a Good Buy Now?

eCommerce technology platform Shopify (NASDAQ:SHOP) delivered impressive returns in 2025…

Will The Magnificent 7 Stocks Go Up This Year?
Will The Magnificent 7 Stocks Go Up This Year?

2025 was another banner year for the Magnificent Seven stocks,…

Stock Ideas

Buy
52
Is NVDA Stock a Buy?

Market Cap: $4.5T
P/E Ratio: 63x

Buy
67
Is GOOG Stock a Buy?

Market Cap: $4T
P/E Ratio: 41x

Buy
53
Is GOOGL Stock a Buy?

Market Cap: $4T
P/E Ratio: 41x

Alerts

Buy
53
FBRX alert for Jan 13

Forte Biosciences, Inc. [FBRX] is up 9.07% over the past day.

Buy
90
BEAM alert for Jan 13

Beam Therapeutics, Inc. [BEAM] is up 2.61% over the past day.

Sell
28
ANF alert for Jan 13

Abercrombie & Fitch Co. [ANF] is up 0.24% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock